04-1017. National Cancer Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of the Advisory Committee to the Director, National Cancer Institute.

    The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National Cancer Institute.

    Date: January 22, 2004.

    Time: 12:30 p.m. to 2 p.m.

    Agenda: The purpose of the meeting will be to discuss the Sarcoma Progress Review Group Report.

    Place: National Cancer Institute, Bldg. 31, Rm. 11A03, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Cherie Nichols, Executive Secretary, National Cancer Institute, National Institutes of Health, Building 31, Room 11A03, Bethesda, MD 20892, (301) 496-5515.

    This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/joint/htm, where an agenda and any additional information for the meeting will be posted when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: January 12, 2004.

    Anna P. Snouffer,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 04-1017 Filed 1-15-04; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
1/22/2004
Published:
01/16/2004
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
04-1017
Dates:
January 22, 2004.
Pages:
2604-2604 (1 pages)
PDF File:
04-1017.pdf